We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:XERS

Xeris Biopharma Holdings (XERS)

Nasdaq • XERS • US98422E1038

15.20Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 4.1% of free float sold short, 2.1 days to cover, cost to borrow 0.36%. Sign up for live short interest data.

Market Cap

2.78b USD | # 3377 in US

Volume

2.62m shares | 24.69m USD

Shares Outstanding

182.7m

Free Float Shares

96.60% | 176.49m

DB:2B30|

LSE:0A8E

News

XERS key data

Xeris Biopharma Holdings (Nasdaq: XERS) has a market capitalization of $2.78B. Last close $15.20 (as of 2026-11-09); 52-week range $5.25 to $15.21. ORTEX data as of 2026-10-22: short interest was 4.07% of free float, 2.1 days to cover and the average cost to borrow was 0.36%. Sign up for live short interest data.

XERS news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.